136 related articles for article (PubMed ID: 33749493)
1. Long-term ovarian reserve and fertility outcomes in female survivors of childhood acute lymphoblastic leukemia.
Elitzur S; Frank S; Goshen-Lago T; Barzilai-Birenboim S; Gilad G; Avrahami G; Goldberg T; Litichever N; Masarwa A; Oron G; Yaniv I; Izraeli S; Ben-Aharon I
Leuk Lymphoma; 2021 Sep; 62(9):2211-2218. PubMed ID: 33749493
[TBL] [Abstract][Full Text] [Related]
2. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
3. Female reproductive function after treatment of childhood acute lymphoblastic leukemia.
Roshandel R; van Dijk M; Overbeek A; Kaspers G; Lambalk C; Beerendonk C; Bresters D; van der Heiden-van der Loo M; van den Heuvel-Eibrink M; Kremer L; Loonen J; van der Pal H; Ronckers C; Tissing W; Versluys B; van Leeuwen F; van den Berg M; van Dulmen-den Broeder E;
Pediatr Blood Cancer; 2021 Apr; 68(4):e28894. PubMed ID: 33459500
[TBL] [Abstract][Full Text] [Related]
4. A survey of ovarian reserve and quality of life in female survivors of pediatric cancer.
Nilsson S; Jarfelt M; Järvholm S; Kluge L; Thurin-Kjellberg A
Acta Obstet Gynecol Scand; 2022 Jan; 101(1):84-93. PubMed ID: 34783360
[TBL] [Abstract][Full Text] [Related]
5. Anti-Müllerian hormone screening to assess ovarian reserve among female survivors of childhood cancer.
Charpentier AM; Chong AL; Gingras-Hill G; Ahmed S; Cigsar C; Gupta AA; Greenblatt E; Hodgson DC
J Cancer Surviv; 2014 Dec; 8(4):548-54. PubMed ID: 24810980
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
Nies M; Cantineau AEP; Arts EGJM; van den Berg MH; van Leeuwen FE; Muller Kobold AC; Klein Hesselink MS; Burgerhof JGM; Brouwers AH; van Dam EWCM; Havekes B; van den Heuvel-Eibrink MM; Corssmit EPM; Kremer LCM; Netea-Maier RT; van der Pal HJH; Peeters RP; Plukker JTM; Ronckers CM; van Santen HM; van der Horst-Schrivers ANA; Tissing WJE; Bocca G; van Dulmen-den Broeder E; Links TP
Thyroid; 2020 Aug; 30(8):1169-1176. PubMed ID: 32079487
[No Abstract] [Full Text] [Related]
7. Early Detection of Ovarian Dysfunction by Anti-Mullerian Hormone in Adolescent and Young Adult-Aged Survivors of Childhood Cancer.
George SA; Williamson Lewis R; Schirmer DA; Effinger KE; Spencer JB; Mertens AC; Meacham LR
J Adolesc Young Adult Oncol; 2019 Feb; 8(1):18-25. PubMed ID: 30281375
[TBL] [Abstract][Full Text] [Related]
8. Ovarian function in female survivors of childhood malignancies.
El-Shalakany AH; Ali MS; Abdelmaksoud AA; Abd El-Ghany S; Hasan EA
Pediatr Hematol Oncol; 2013 May; 30(4):328-35. PubMed ID: 23574301
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss.
van der Kooi AL; van den Heuvel-Eibrink MM; van Noortwijk A; Neggers SJ; Pluijm SM; van Dulmen-den Broeder E; van Dorp W; Laven JS
Hum Reprod; 2017 Jan; 32(1):193-200. PubMed ID: 27821706
[TBL] [Abstract][Full Text] [Related]
10. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
[TBL] [Abstract][Full Text] [Related]
11. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
[TBL] [Abstract][Full Text] [Related]
12. Antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) are the predictors of natural fecundability have similar trends irrespective of fertility status and menstrual characteristics among fertile and infertile women below the age of 40 years.
Khan HL; Bhatti S; Suhail S; Gul R; Awais A; Hamayun H; Enver F; Abbas S; Hassan Z; Nisar R; Sardar S; Asif W
Reprod Biol Endocrinol; 2019 Feb; 17(1):20. PubMed ID: 30744650
[TBL] [Abstract][Full Text] [Related]
13. Extended fertility at highly advanced reproductive age is not related to anti-Müllerian hormone concentrations.
Rotshenker-Olshinka K; Michaeli J; Srebnik N; Samueloff A; Magen S; Farkash R; Eldar-Geva T
Reprod Biomed Online; 2022 Jul; 45(1):147-152. PubMed ID: 35534396
[TBL] [Abstract][Full Text] [Related]
14. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
15. The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.
Pilsgaard F; Grynnerup AG; Løssl K; Bungum L; Pinborg A
Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1105-1113. PubMed ID: 29476703
[TBL] [Abstract][Full Text] [Related]
16. Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study.
Rossi G; Kicinski M; Suciu S; Vandecruys E; Plat G; Uyttebroeck A; Paillard C; Barbati M; Dresse MF; Simon P; Minckes O; Pluchart C; Ferster A; Freycon C; Millot F; van der Werff Ten Bosch J; Chantrain C; Paulus R; de Rojas T; de Schaetzen G; Rohrlich P; Benoit Y; Piette C
Hum Reprod; 2021 Dec; 37(1):44-53. PubMed ID: 34788455
[TBL] [Abstract][Full Text] [Related]
17. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
[TBL] [Abstract][Full Text] [Related]
18. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of ovarian reserve in childhood and adolescence: A systematic review.
Bhide P; Pundir J; Homburg R; Acharya G
Acta Obstet Gynecol Scand; 2019 May; 98(5):563-572. PubMed ID: 30758847
[TBL] [Abstract][Full Text] [Related]
20. Anti-Müllerian Hormone in Female Adolescent Cancer Patients Before, During, and After Completion of Therapy: A Pilot Feasibility Study.
Gupta AA; Lee Chong A; Deveault C; Traubici J; Maloney AM; Knight S; Lorenzo A; Allen L
J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):599-603. PubMed ID: 27184535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
